Printer Friendly

The Female Health Company announces up to 11m FC2(R) Female Condoms tender.

M2 PHARMA-June 29, 2015-The Female Health Company announces up to 11m FC2(R) Female Condoms tender


The Female Health Company (NasdaqCM:FHCO) reported on Friday the receipt of a recent tender of up to 11m units FC2(R) Female Condoms.

This tender was awarded to the company's distributor in the Republic of South Africa, Barrs Medical (Pty) Ltd.

Based in Chicago, Illinois, The Female Health Company manufactures and markets the FC2 Female Condom (FC2).

According to the company, it owns certain worldwide rights to the FC2 Female Condom(R), including patents that have been issued in a number of countries around the world. The patents cover the key aspects of FC2, including its overall design and manufacturing process. It is the only currently available female-controlled product approved by US FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy.

((Comments on this story may be sent to

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jun 29, 2015
Previous Article:Siemens collaborates with BioNTech.
Next Article:SteadyMed signs exclusive license and supply agreement with Cardiome Pharma for Trevyent.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters